Pau d'Arco.Shop Taheebo Tea

Inflammation

Pau d'Arco and Inflammation

Published 2026-04-11· Updated 2026-09-26

Important disclaimer

This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Pau d'Arco is not intended to diagnose, treat, cure, or prevent any disease. We summarize published research and traditional use — this is not a recommendation to use Pau d'Arco for any specific condition. Always consult a qualified healthcare professional before starting a new supplement, especially alongside an existing medical condition or medication.

Acute inflammation is a protective immune response; chronic inflammation is increasingly linked to conditions from osteoarthritis to inflammatory bowel disease. Pau d'Arco (Tabebuia impetiginosa) has a long traditional history of use for fevers, infections, and joint pain, and modern research has looked at specific mechanisms behind that use. As with the rest of this site, mechanism research and a treatment claim are two different things — this article keeps them separate.

Evidence key:Traditional UseLab / In VitroAnimal StudyHuman Trial

The Chemical Basis: Naphthoquinones and Quercetin

Pau d'Arco's anti-inflammatory research centers on its naphthoquinones (lapachol, beta-lapachone) alongside quercetin, a well-studied antioxidant flavonoid. Lab research describes a "multi-targeted" effect on inflammatory signaling, rather than blocking a single enzyme the way many pharmaceutical anti-inflammatories do.

Prostaglandin and COX-2 Research

Lab / In Vitro

A study using water-based Pau d'Arco extracts found significant inhibition of prostaglandin production — the hormone-like substances that mediate pain, fever, and swelling — reportedly by suppressing the COX-2 enzyme, the same target as many NSAIDs. This is an extract study, not a human trial, and it doesn't mean Pau d'Arco tea works like or replaces an NSAID; talk to a doctor about managing diagnosed pain or inflammation.

Source: Journal of Ethnopharmacology (2008)

A 2020 review in Phytochemistry also discussed beta-lapachone's role in animal models of inflammatory bowel disease and asthma, reporting lower pro-inflammatory markers — again, animal-model evidence.

NF-κB and Cytokine Suppression

At the center of the inflammatory response is NF-κB, a protein complex that, when activated, switches on genes producing pro-inflammatory cytokines like TNF-alpha and IL-6.

Lab / In Vitro

Pau d'Arco extracts have been reported to block the NF-κB and AP-1 signaling pathways in lab research, and to lower production of TNF-α and IL-1β — in LPS-stimulated human THP-1 cells and, in one 2021 study, in primary human lymphocytes tested ex vivo. This immunomodulatory mechanism — shifting the balance of pro- and anti-inflammatory signaling rather than broadly suppressing the immune system — shows up across several of this site's topics, including gut balance, cancer-related inflammatory pathways, and Candida.

Source: Fitoterapia (2012); Scientific Reports (2021); Mediators of Inflammation (2017)

Joint and Cartilage Research

Animal Study

Research on matrix metalloproteinases (MMP-3, MMP-8, MMP-9) — enzymes involved in cartilage breakdown in osteoarthritis — has reported reduced MMP activity and chondroprotective effects with a standardized Tabebuia avellanedae ethanol extract in a monoiodoacetate-induced osteoarthritis model. This is animal-model research, not a clinical trial in people with osteoarthritis.

Source: Mediators of Inflammation (2017)

Pain and Swelling Models

Pending medical review. This section was added on September 26, 2026 and has not yet been reviewed by our medical reviewer.

Animal Study

In rodent pain models (hot-plate and writhing tests), a 200 mg/kg dose of an ethanolic extract of Tabebuia avellanedae inner bark raised the pain threshold by about 30% compared with controls. In vascular-permeability and paw-edema models, the same dose inhibited inflammation by 30–50%. At 100 mg/kg the extract lowered pain and inflammation in every model, but the difference was not statistically significant. This is an ethanol extract given to animals, not brewed tea taken by people, and it does not show pain relief in humans.

Source: Molecular Medicine Reports (2012)

The Decoction Method

The active compounds aren't highly water-soluble, so a simple infusion under-extracts them:

  • 3 tablespoons of high-quality inner bark (fine grind) per 4½ cups of water, in a glass or stainless steel pot.
  • Bring to a boil, then reduce heat, cover, and simmer 25 minutes.
  • Strain through a fine mesh filter.
  • Traditional-use guidance is generally 1–2 cups daily, up to 3–4 for more intensive support, adjusted for tolerance.

We follow this same method for Taheebo Wellness Tea — see our FAQ for more on dosage and sourcing.

Precautions and Considerations

  • Pregnancy and breastfeeding: avoid — isolated lapachol has shown abortifacient properties in animal studies; no human safety data confirms whole-bark tea is different.
  • Blood-thinning effects: consult a doctor if on prescription blood thinners or scheduled for surgery.
  • GI sensitivity: high doses may cause mild nausea; reduce dose or take with food.
  • Quality control: use inner bark of Tabebuia impetiginosa/avellanedae — see our sourcing guide.

Where This Leaves Us

The mechanism research on Pau d'Arco and inflammation spans a real range — COX-2, NF-κB, MMP enzymes — but nearly all of it sits at the lab or animal-model tier. If you're managing a diagnosed inflammatory condition, this is background reading, not a treatment plan; that conversation belongs with your healthcare provider.

References

  1. 1.Journal of Ethnopharmacology (2008): "In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae."
  2. 2.Molecules (2020): "Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties."
  3. 3.Phytochemistry (2021): "Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis."
  4. 4.Mediators of Inflammation (2017): "Tabetri (Tabebuia avellanedae Ethanol Extract) Ameliorates Osteoarthritis Symptoms Induced by Monoiodoacetate through Its Anti-Inflammatory and Chondroprotective Activities."
  5. 5.Fitoterapia (2012): "Anti-inflammatory constituents from Tabebuia avellanedae" (inhibition of TNF-α and IL-1β in LPS-stimulated human THP-1 cells)
  6. 6.Scientific Reports (2021): "The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes"
  7. 7.Molecular Medicine Reports (2012): "Analgesic and anti-inflammatory effects in animal models of an ethanolic extract of Taheebo, the inner bark of Tabebuia avellanedae."
Carol Wade, RH (AHG)

Reviewed by

Carol Wade, RH (AHG) — Clinical Herbalist, Ojai School of Herbal Studies